Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Number of items: 3.

Journal Article

Burmester, Gerd, McInnes, Iain B., Kremer, Joel M., Miranda, Pedro, Korkosz, Mariusz, Vencovsky, Jiri ORCID: 0000-0002-0851-0713, Rubbert-Roth, Andrea, Mysler, Eduardo, Sandbach, Sara, Sleeman, Matthew A., Godwood, Alex, Close, David and Weinblatt, Michael (2014). Efficacy and Safety/Tolerability of Mavrilimumab, a Human GM-CSFRa Monoclonal Antibody in Patients with Rheumatoid Arthritis. Arthritis Rheumatol., 66. S. S1231 - 2. HOBOKEN: WILEY-BLACKWELL. ISSN 2326-5205

Burmester, Gerd R., McInnes, Iain B., Kremer, Joel, Miranda, Pedro, Korkosz, Mariusz, Vencovsky, Jiri ORCID: 0000-0002-0851-0713, Rubbert-Roth, Andrea, Mysler, Eduardo, Sleeman, Matthew A., Godwood, Alex, Sinibaldi, Dominic, Guo, Xiang, White, Wendy I., Wang, Bing, Wu, Chi-Yuan, Ryan, Patricia C., Close, David and Weinblatt, Michael E. (2017). A randomised phase IIb study of mavrilimumab, a novel GM-CSF receptor alpha monoclonal antibody, in the treatment of rheumatoid arthritis. Ann. Rheum. Dis., 76 (6). S. 1020 - 1031. LONDON: BMJ PUBLISHING GROUP. ISSN 1468-2060

McInnes, Iain B., Burmester, Gerd, Kremer, Joel M., Miranda, Pedro, Korkosz, Mariusz, Vencovsky, Jiri ORCID: 0000-0002-0851-0713, Rubbert-Roth, Andrea, Mysler, Eduardo, Close, David, Sleeman, Matthew A., Godwood, Alex, Sandbach, Sara, Ryan, Patricia C., Sinibaldi, Dominic, White, Wendy, Defranoux, Nadine A. and Weinblatt, Michael (2014). Rapid Onset of Clinical Benefit Is Associated with a Reduction in Validated Biomarkers of Disease in Patients with Rheumatoid Arthritis Treated with Mavrilimumab, a Human Monoclonal Antibody Targeting GM-CSFRa. Arthritis Rheumatol., 66. S. S653 - 2. HOBOKEN: WILEY-BLACKWELL. ISSN 2326-5205

This list was generated on Fri Mar 29 13:24:34 2024 CET.